Clinical Trial: Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-339 in Healthy Volunteers

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07748702) titled 'Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-339 in Healthy Volunteers' on July 28.

Brief Summary: This study is a randomized, open-label, single dose, crossover study to evaluate the pharmacokinetics and safety of CKD-339 in healthy volunteers.

Study Start Date: Aug. 20

Study Type: INTERVENTIONAL

Condition: Hypertension

Intervention: DRUG: CKD-339

QD, PO

DRUG: D311, D107

QD, PO

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Chong Kun Dang Pharmaceutical

Published by HT Digital Content Services with permission from Health Daily Digest....